A Phase 2, Single Arm Study of Iniparib in Patients With BRCA1 or BRCA2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
about
Update on Poly-ADP-ribose polymerase inhibition for ovarian cancer treatmentTargeted Proteomic Analyses of Histone H4 Acetylation Changes Associated with Homologous-Recombination-Deficient High-Grade Serous Ovarian Carcinomas.Current status of poly(ADP-ribose) polymerase inhibitors and future directions.Risk of selected gastrointestinal toxicities associated with poly (ADP-ribose) polymerase (PARP) inhibitors in the treatment of ovarian cancer: a meta-analysis of published trials
P2860
A Phase 2, Single Arm Study of Iniparib in Patients With BRCA1 or BRCA2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A Phase 2, Single Arm Study of ...... or Primary Peritoneal Cancer.
@en
A Phase 2, Single Arm Study of ...... or Primary Peritoneal Cancer.
@nl
type
label
A Phase 2, Single Arm Study of ...... or Primary Peritoneal Cancer.
@en
A Phase 2, Single Arm Study of ...... or Primary Peritoneal Cancer.
@nl
prefLabel
A Phase 2, Single Arm Study of ...... or Primary Peritoneal Cancer.
@en
A Phase 2, Single Arm Study of ...... or Primary Peritoneal Cancer.
@nl
P2093
P2860
P1476
A Phase 2, Single Arm Study of ...... or Primary Peritoneal Cancer.
@en
P2093
Alexia Iasonos
Carol Aghajanian
Eric Charpentier
Katherine M Bell-McGuinn
Martee L Hensley
Paul Sabbatini
Svetlana Mironov
William P Tew
P2860
P304
P356
10.1097/IGC.0000000000000591
P50
P577
2016-01-08T00:00:00Z